中医临床研究数据库
中医临床研究
在线投稿
过刊浏览

非酒精性脂肪性肝病中医证候及临床特点分析

浏览数:131 

非酒精性脂肪性肝病中医证候及临床特点分析

An analysis of TCM syndromes and clinicalcharacteristics

of nonalcoholic fatty liver


李满容

(乐山市中医医院,四川  乐山,614000)

类号:R256.4    献标识码:A    文章编号:1674-7860(2015)27-0017-02    :DBGI

【摘  要】目的:分析非酒精性脂肪性肝病患者的中医证候和临床特点。方法:选自20121月—201412月,在我院治疗非酒精性脂肪性肝病的患者100例,分析其中医证候,并观察其临床特点。结果:乏力占89.0%,善太息占72.0%,口干口苦占82.0%,胁肋胀痛占42.0%,肢困占29.0%,恶心占50.0%,失眠占57.0%,食欲不振占70.0%,大便干结占51.0%,口黏腻占54.0%,尿黄占52.0%,大便稀溏占56.0%,烦躁易怒占44.0%,脘腹痞闷占52.0%,腰膝酸软占50.0%,形体肥胖占80.0%,舌质暗淡占15.0%,舌质暗红占32.0%,舌有瘀斑占12.0%,舌有齿痕占16.0%,舌质淡红占27.0%,苔薄白占22.0%,苔黄腻占48.0%,苔白腻占31.0%。结论:通过分析非酒精性脂肪性肝病患者的中医证候和临床特点,能够为临床诊断和治疗患者提供有效的参考依据。

【关键词】非酒精性脂肪性肝病;中医证候;临床特点

AbstractObjective: To analyze the clinicalcharacteristics TCM syndromes of nonalcoholic fatty liver. Methods: 100patients with non alcoholic fatty liver disease were analyzed. Result: Tired, accountedfor 89.0%; Shantaixi, accounted for 72.0%; Dry and bitter mouth,  accounted for 82.00%; Rid pain, accounted for42.0%; Weak limb, accounted for 29.0%; Nausea, take 50.0%; Insominia take 57.0%,appetite weak accounted for 70%, stool dry accounted for 51%, mouth stickygreasy accounted for 54%, urine yellow accounted for 52%, stool dilute pondaccounted for 56%, upset easy anger accounted for 44%, abdominal ruffian stuffyaccounted for 52%, weak waist knee limp accounted for 50%, obesity accountedfor 80%, tongue dark accounted for 15%, tongue dark red accounted for 32%,Tongue petechiae, 12%, tongue with tooth marks 16%, 27% tongue pink; thin,white tongue coating 22%; yellow greasy Moss, 48%; sick of white fur 31%.Conclusion: With TCM syndromes and clinical characteristics of nonalcoholicfatty liver, effective reference can be provided for clinical diagnosis andtreatment.

KeywordsNonalcoholic fatty liver disease; TCMsyndrome; Clinical characteristics

doi:10.3969/j.issn.1674-7860.2015.27.007

请点击此处【在线阅读全文PDF格式】

详情可登录【万方数据】

也可登录【中国知网】


在线客服
 
 
 工作时间
周一至周五 :8:30-17:00
周六至周六 :8:30-17:00
 联系方式
地址:北京市樱花园东街甲4号
邮箱:cccjcm@163.com
电话:010-59420369
全站搜索
 
 
请关注我们